Literature DB >> 4562476

Comparison of immunization methods for producing reference adenovirus antisera in horses.

J C Hierholzer, W C Gamble, K D Quist, W A Chappell.   

Abstract

Horses were immunized by a variety of inoculation procedures designed to determine the most efficient method of producing antisera to adenovirus types 25 to 31. The procedures evaluated included immunization by (i) direct intravenous (iv) injection, (ii) iv infusion, (iii) intramuscular (im) injection of virus with and without Freund's incomplete adjuvant, (iv) combined iv and im injections, and (v) combined iv infusion and im injection. The im schedule (no. 3) was superior to the others in terms of immunizing antigen and time required, and hemagglutination-inhibition (HI) and serum-neutralizing (SN) antibody levels produced. HI and SN tests performed with sera before and after heating at 56 C for 30 min showed that heat-inactivation was not necessary for tests with equine antisera.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4562476      PMCID: PMC376530          DOI: 10.1128/am.24.3.398-404.1972

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  22 in total

1.  Method for testing virus stocks for viral contaminants.

Authors:  B Hampil; J L Melnick
Journal:  Appl Microbiol       Date:  1969-01

2.  [Inhibitors of adenovirus hemagglutination and spontaneous hemagglutinins in the sera of animals and humans].

Authors:  E E Zolotarskaia; R S Dreĭzin
Journal:  Vopr Virusol       Date:  1968 Jan-Feb

3.  [Serological relationship of group II adenoviruses].

Authors:  R Wigand
Journal:  Arch Gesamte Virusforsch       Date:  1968

4.  Serologically intermediate adenovirus strains: a regular feature of group II adenoviruses.

Authors:  R Wigand; D Fliedner
Journal:  Arch Gesamte Virusforsch       Date:  1968

5.  Method for extracting viral hemagglutination-inhibiting antibodies from the nonspecific inhibitors of serum.

Authors:  W A Altemeier; F K Mundon; F H Top; P K Russell
Journal:  Appl Microbiol       Date:  1970-05

6.  Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics.

Authors:  M D Hoggan; N R Blacklow; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1966-06       Impact factor: 11.205

7.  Standardization and certification of reference antigens and antisera for 30 human adenovirus serotypes.

Authors:  D A Stevens; M Schaeffer; J P Fox; C D Brandt; M Romano
Journal:  Am J Epidemiol       Date:  1967-11       Impact factor: 4.897

8.  Standardized viral hemagglutination and hemagglutination-inhibition tests. I. Standardization of erythrocyte suspensions.

Authors:  J C Hierholzer; M T Suggs
Journal:  Appl Microbiol       Date:  1969-11

9.  Hemagglutination properties of adenovirus types 20, 25, and 28.

Authors:  J C Hierholzer; W R Dowdle
Journal:  Proc Soc Exp Biol Med       Date:  1970-06

10.  Standardized viral hemagglutination and hemagglutination-inhibition tests. II. Description and statistical evaluation.

Authors:  J C Hierholzer; M T Suggs; E C Hall
Journal:  Appl Microbiol       Date:  1969-11
View more
  8 in total

1.  Effect of adjuvant vaccines on dengue virus type 2 immune ascitic fluid production.

Authors:  W C Gamble; E H George; M B Fears; D W Sanderlin; W A Chappell
Journal:  J Clin Microbiol       Date:  1985-03       Impact factor: 5.948

2.  New human adenovirus associated with respiratory illness: candidate adenovirus type 39.

Authors:  J C Hierholzer; M C Kemp; G W Gary; H C Spencer
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

3.  Reference equine antisera to 33 human adenovirus types: homologous and heterologous titers.

Authors:  J C Hierholzer; W C Gamble; W R Dowdle
Journal:  J Clin Microbiol       Date:  1975-01       Impact factor: 5.948

4.  New human adenovirus isolated from a renal transplant recipient: description and characterization of candiate adenovirus type 34.

Authors:  J C Hierholzer; N O Atuk; J M Gwaltney
Journal:  J Clin Microbiol       Date:  1975-04       Impact factor: 5.948

5.  Antigenic characterization of intermediate adenovirus 14-11 strains associated with upper respiratory illness in a military camp.

Authors:  J C Hierholzer; A Pumarola
Journal:  Infect Immun       Date:  1976-02       Impact factor: 3.441

6.  Production of influenza virus complement-fixing antibody in mouse ascitic fluid.

Authors:  L A White; W C Gamble; W A Chappell
Journal:  J Clin Microbiol       Date:  1975-10       Impact factor: 5.948

7.  Antigenic relationships among the 47 human adenoviruses determined in reference horse antisera.

Authors:  J C Hierholzer; Y O Stone; J R Broderson
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  New human adenovirus (candidate adenovirus type 35) causing fatal disseminated infection in a renal transplant recipient.

Authors:  H Stalder; J C Hierholzer; M N Oxman
Journal:  J Clin Microbiol       Date:  1977-09       Impact factor: 5.948

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.